Core Viewpoint - The company, Pianzaihuang (600436.SH), is actively seeking new growth points within the health industry chain while ensuring the development of its main business by investing in the Zhangzhou Gaoxin Runxin Health Industry Investment Partnership (Limited Partnership) with a target fundraising scale of 1 billion yuan [1] Group 1: Investment Details - The company’s wholly-owned subsidiary, Pianzaihuang Investment, plans to invest 200 million yuan, accounting for 20% of the target fundraising scale of the Gaoxin Runxin Fund [1] - The primary investment areas of the fund include the healthcare sector, covering pharmaceuticals, medical devices, upstream supply chains, health food, synthetic biology, chemical materials, and consumer healthcare [1] - Investments outside the healthcare sector will not exceed 10% of the fund's subscribed capital [1]
片仔癀(600436.SH)子公司拟出资2亿元参投高鑫润信基金